ECSP099680A - Métodos para preparar compuestos basados en imidazol - Google Patents

Métodos para preparar compuestos basados en imidazol

Info

Publication number
ECSP099680A
ECSP099680A EC2009009680A ECSP099680A ECSP099680A EC SP099680 A ECSP099680 A EC SP099680A EC 2009009680 A EC2009009680 A EC 2009009680A EC SP099680 A ECSP099680 A EC SP099680A EC SP099680 A ECSP099680 A EC SP099680A
Authority
EC
Ecuador
Prior art keywords
methods
imidazol
prepare
based compounds
imidazole
Prior art date
Application number
EC2009009680A
Other languages
English (en)
Inventor
Wenxue Wu
Haiming Zhang
Jie Yan
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP099680(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of ECSP099680A publication Critical patent/ECSP099680A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen métodos para preparar compuestos basados en imidazol. Los compuestos particulares son de fórmula (I).Gráfico (Imagen en formato jpg) 6 figuras adicionales incluidas en documento técnico
EC2009009680A 2007-04-12 2009-10-07 Métodos para preparar compuestos basados en imidazol ECSP099680A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92302907P 2007-04-12 2007-04-12

Publications (1)

Publication Number Publication Date
ECSP099680A true ECSP099680A (es) 2009-12-28

Family

ID=39580118

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009680A ECSP099680A (es) 2007-04-12 2009-10-07 Métodos para preparar compuestos basados en imidazol

Country Status (22)

Country Link
US (2) US7812174B2 (es)
EP (1) EP2139864B1 (es)
JP (1) JP5398698B2 (es)
KR (1) KR20100015463A (es)
CN (1) CN101284817B (es)
AR (1) AR065980A1 (es)
AU (1) AU2008240251A1 (es)
BR (1) BRPI0810993A2 (es)
CA (1) CA2683445A1 (es)
CL (1) CL2008001042A1 (es)
CO (1) CO6231030A2 (es)
EA (1) EA017076B1 (es)
EC (1) ECSP099680A (es)
IL (1) IL201075A0 (es)
MX (1) MX2009010903A (es)
NZ (1) NZ579691A (es)
PE (1) PE20090699A1 (es)
TW (1) TWI389891B (es)
UA (1) UA97664C2 (es)
UY (1) UY31013A1 (es)
WO (1) WO2008128041A2 (es)
ZA (2) ZA200906578B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR065980A1 (es) * 2007-04-12 2009-07-15 Lexicon Pharmaceuticals Inc Metodos para preparar compuestos basados en imidazol
TWI412362B (zh) * 2007-04-12 2013-10-21 Lexicon Pharmaceuticals Inc （ｅ）-１-（４-（（１ｒ，２ｓ，３ｒ）-１，２，３，４-四羥丁基）-１ｈ-咪唑-２-基）乙酮肟的固體形式
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
TW201002698A (en) * 2008-06-18 2010-01-16 Lexicon Pharmaceuticals Inc Methods of preparing imidazole-based bicyclic compounds
AR074062A1 (es) * 2008-10-31 2010-12-22 Lexicon Pharmaceuticals Inc Agonistas del receptor s1p para el tratamiento de la malaria cerebral y forma farmaceutica
AU2010313521B2 (en) * 2009-10-26 2014-01-30 Lexicon Pharmaceuticals, Inc. Methods of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone
CN102082785A (zh) * 2010-11-24 2011-06-01 蓝帽子(厦门)文化传播有限公司 线上线下游戏数据交互传输的认证加密装置及其认证方法
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567194A (en) * 1983-03-10 1986-01-28 The Coca-Cola Company 2-Acylimidazole compounds, their synthesis and use as medicinal agents
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
AR065980A1 (es) * 2007-04-12 2009-07-15 Lexicon Pharmaceuticals Inc Metodos para preparar compuestos basados en imidazol
TWI412362B (zh) * 2007-04-12 2013-10-21 Lexicon Pharmaceuticals Inc （ｅ）-１-（４-（（１ｒ，２ｓ，３ｒ）-１，２，３，４-四羥丁基）-１ｈ-咪唑-２-基）乙酮肟的固體形式

Also Published As

Publication number Publication date
ZA201006678B (en) 2012-05-30
WO2008128041A2 (en) 2008-10-23
PE20090699A1 (es) 2009-07-08
UY31013A1 (es) 2008-09-02
AR065980A1 (es) 2009-07-15
AU2008240251A1 (en) 2008-10-23
TWI389891B (zh) 2013-03-21
CL2008001042A1 (es) 2008-09-12
CA2683445A1 (en) 2008-10-23
EP2139864B1 (en) 2015-12-02
JP5398698B2 (ja) 2014-01-29
CN101284817A (zh) 2008-10-15
NZ579691A (en) 2011-12-22
EA017076B1 (ru) 2012-09-28
US20110071303A1 (en) 2011-03-24
HK1124842A1 (en) 2009-07-24
CN101284817B (zh) 2013-06-26
ZA200906578B (en) 2010-11-24
US7812174B2 (en) 2010-10-12
WO2008128041A3 (en) 2009-09-24
JP2010523706A (ja) 2010-07-15
BRPI0810993A2 (pt) 2018-10-16
US8093280B2 (en) 2012-01-10
EP2139864A2 (en) 2010-01-06
US20080262241A1 (en) 2008-10-23
TW200902502A (en) 2009-01-16
IL201075A0 (en) 2010-05-17
CO6231030A2 (es) 2010-12-20
MX2009010903A (es) 2009-10-26
EA200970939A1 (ru) 2010-04-30
UA97664C2 (uk) 2012-03-12
KR20100015463A (ko) 2010-02-12

Similar Documents

Publication Publication Date Title
ES2538103T3 (es) Método de síntesis mejorado para la síntesis de pirfenidona
CL2016001732A1 (es) Métodos sintéticos para compuestos espiro-oxoindol (div. sol. 3633-13).
NI200900213A (es) Pirazol amidas de ácido carboxílico útiles como microbicidas.
CR10156A (es) Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos
MY152114A (en) Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
EP2470527A4 (en) ETHER-benzotriazole
GB2437009A (en) Ranking system
JP2012527477A5 (es)
FR2939913B1 (fr) Panneau solaire permettant la visualisation d'une image.
CR20120033A (es) Derivados de 5-fluoro-2-oxopirimidina-1-(2h) carboxilato.
EA201171329A1 (ru) Твердый препарат
ECSP11011245A (es) Novedosos herbicidas
NI201100139A (es) Microbiocidas nuevos.
UY31013A1 (es) Metodos para prepar compuestos basados en imidazol
CR20120502A (es) Uso de nuevos inhibidores de pan-cdk para tratar tumores
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
MX2012007385A (es) Derivados de aminoalquilpirimidina como anatagonistas del receptor h4 de histamina.
IT1399755B1 (it) Cella di base per implementazione di un ordine di modifica o engineering change order (eco) perfezionata.
EA201200017A1 (ru) Новая кристаллическая форма пемироласта
IN2012DN01223A (es)
IT1396197B1 (it) Cassetta di derivazione, particolarmente per linee di illuminazione per gallerie
IN2012DN02698A (es)
DE602006021327D1 (de) Isochinoline als igf-1r-inhibitoren
CO6341619A2 (es) Metodos para preparar compuestos biciclicos basados en imidazol
PA8786201A1 (es) Proceso para la preparación de 17-(3-hidroxipropil)-17-hidroxiesteroides